Oncolytics Biotech Inc. (ONCY)

[wizeman]

One very big positive is that Reolysin has shown great resilience to any negative findings or placebos. Every conclusion thus far has magnified the collaboration of many types of cancer treatments and Reolysin as beneficial. Investors that jumped in after the last PR were greater than in any event or release in Oncolytic's history. They're now more comfortable recommending ONCY as something seen to treat cancer effectively and the volume proved it. If Oncolytics continues getting FDA approval and Phases are found favorable these W shaped trading days could vanish.

Great job to the folks working to solve another major disease that costs evey nation 100s of billions every year. Even a small part of resolving that by the Folks at Oncolytics Biotech good be a huge win for investors!